Metabolic Research
AOD-9604
Modified fragment of human growth hormone studied historically for metabolic hypotheses. Not an established approved obesity medicine.
Limited Human EvidenceExperimental
View peptide →
Understand peptides. Follow the research.
Explore peptides, mechanisms, evidence, safety information, research, and research-use vials in one live knowledge platform.
Live library snapshot
Indexed peptides
15
Sourced profiles
Study cards
11
With real citations
Categories
11
Research areas
Articles
8
Educational explainers
Reconstitution calculator
Volume math for research amounts. Protocol chips are unofficial community figures, not medical advice and not approved labeling. Open the full page for lab reconstitution notes. This tool does not provide injection technique.
Peptide products
Search a vial size to fill amount and water. Mixes are community examples, not labeling.
Peptide amount in vial (mg)
Bacteriostatic water added (mL)
Desired dose
Live snapshot
1.0 ml U-100 syringe
Enter inputs to see units
1 unit = 0.01 mL. This syringe holds 100 units. The fill line is the number to draw to.
Peptide dose
—
Amount in one draw
Draw syringe to
—
U-100 barrel mark
Doses in vial
—
At this research amount
Concentration
—
Finished solution strength
Results use a U-100 syringe: 1 unit = 0.01 mL. Open the full calculator page
Peptide library
Approved medicines and experimental compounds in one catalog, separated by evidence. Filter, then open a profile. You can also browse the full library, research categories, or sourced studies.
Tissue Research
BPC-157
Experimental pentadecapeptide investigated primarily in preclinical gastrointestinal and tissue-injury models. Human evidence is extremely limited.
PreclinicalExperimental
View peptide →
Growth Hormone Research
CJC-1295
Long-acting GHRH analog studied in healthy adults for prolonged GH and IGF-I secretion. Not an approved therapy for general use.
Limited Human EvidenceExperimental
View peptide →
Longevity Research
Epitalon
Synthetic tetrapeptide associated with pineal peptide research and aging hypotheses. Human anti-aging efficacy is not established.
ExperimentalExperimental
View peptide →
Growth Hormone Research
GHRP-2
Ghrelin-receptor GH secretagogue used in some diagnostic and research contexts. Not established as an FDA-approved wellness therapy.
Limited Human EvidenceExperimental
View peptide →
Growth Hormone Research
GHRP-6
Older ghrelin-receptor GH secretagogue known experimentally to stimulate GH and, in some contexts, appetite. Not an approved medicine.
Limited Human EvidenceExperimental
View peptide →
Growth Hormone Research
Ipamorelin
Selective ghrelin-receptor GH secretagogue characterized mainly in experimental models. Not an approved medicine.
PreclinicalExperimental
View peptide →
Metabolic Research
MOTS-c
Mitochondrial-derived peptide studied in cell and mouse metabolic models. Human therapeutic use is not established.
PreclinicalEarly research
View peptide →
Neurological Research
Selank
Synthetic tuftsin-derived heptapeptide studied for anxiolytic and nootropic hypotheses, including work outside the U.S. Not FDA-approved.
Limited Human EvidenceExperimental
View peptide →
Metabolic Research
Semaglutide
GLP-1 receptor agonist approved in the United States for specific diabetes and weight-management indications, depending on product and labeling.
EstablishedApproved medicine
View peptide →
Neurological Research
Semax
Synthetic ACTH fragment analog studied as a nootropic/neuroprotective candidate in some countries. Not FDA-approved.
Limited Human EvidenceExperimental
View peptide →
Growth Hormone Research
Sermorelin
GHRH (1-29) analog that was previously marketed in the U.S. Current routine availability and approved status should not be assumed from historical branding.
Limited Human EvidenceClinical investigation
View peptide →
Tissue Research
TB-500
Marketed research peptide associated with thymosin beta-4 biology. Clinical effectiveness and product identity are not sufficiently established.
PreclinicalExperimental
View peptide →
Growth Hormone Research
Tesamorelin
Growth hormone–releasing factor analog approved to reduce excess abdominal fat in HIV-infected adults with lipodystrophy — not a general weight-loss medicine.
EstablishedApproved medicine
View peptide →
Metabolic Research
Tirzepatide
Dual GIP and GLP-1 receptor agonist approved in the United States for specific diabetes and weight-related indications, depending on product labeling.
EstablishedApproved medicine
View peptide →
Compare peptides
Place up to three profiles side by side. This tool does not rank peptides. Open the compare page.
No peptides selected
Choose up to three peptides to open the comparison table.
Research vials
Sold in packs of 10 vials. Each card is a peptide with multiple strengths. Checkout is on Telegram.
Evidence mix
Counts from the indexed library, not estimated market size.
Recently viewed
Open a peptide profile and it will appear here on this device.
How the platform works
Search the graph
Find peptides, aliases, glossary terms, studies, and articles from one command palette.
Read the evidence layer
Every profile leads with evidence level, research status, and what is still unknown.
Follow the sources
Claims are tied to DailyMed, PubMed, and other official or peer-reviewed records — never invented IDs.
Evidence system
Established is not a guarantee. Experimental is not an insult. The badge tells you how far the human evidence has actually traveled.
Established
Clinical research
Limited human
Preclinical
Experimental
Safety-first approach
This platform provides general educational information about peptides and related research. It is not medical advice and does not replace consultation with a qualified healthcare professional. Some peptides discussed on this platform may be experimental or investigational and may not be approved for human use.
Read the safety page and source list.
Myths & facts
Myth
More research papers mean a peptide is proven.
Fact
Research volume alone does not establish effectiveness or safety. Study type, species, size, and bias matter more than count.
Myth
If a peptide is sold online, it must be an approved medicine.
Fact
Research-chemical and compounding markets are not the same as FDA-approved, labeled products.
Myth
Animal healing models predict human sports recovery.
Fact
Preclinical injury models often fail to translate. Human outcomes require human evidence.
Myth
All 'GH peptides' work the same way.
Fact
GHRH-receptor agonists and ghrelin-receptor secretagogues are different mechanisms, with different evidence and regulatory stories.
Myth
No reported side effects in a forum means a compound is safe.
Fact
Absence of systematic safety collection is not evidence of safety. Unregulated products add identity and contamination uncertainty.
Myth
Established evidence means a medicine is right for you.
Fact
Approved uses are population- and indication-specific. Personal decisions require a qualified clinician and the product label.
Latest articles
FAQ
Is this medical advice?
No. It is general educational information. Personal decisions belong with a qualified clinician.
Do you recommend doses?
No. The reconstitution calculator does volume math for research amounts. The full calculator page has general lab reconstitution notes. It is not a personal dose or injection protocol.
Why are experimental peptides listed?
Because people search for them. Listing a compound is not an endorsement of use.
Can I trust the citations?
We only attach real PubMed IDs and official labels. Gaps are labeled as not sufficiently established.
Do you sell peptides?
Research-use vials are sold in packs of 10 on the shop. Checkout is on Telegram. That catalog is not a prescription and not for human or veterinary use.